We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Approach to Skull Restoration Reduces Harm to Brain

By HospiMedica International staff writers
Posted on 19 Feb 2014
A safer method to replace cranium bone removed after brain surgery results in fewer complications than standard restoration, according to a new study.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) have developed a multidisciplinary technique for secondary cranial reconstruction, the procedure used to restore the piece of skull removed to accommodate a swelling brain caused by brain injury, infection, tumor, or stroke. More...
The time lag between removal and replacement often results in the scalp adhering to the outer layer of the brain; when peeling back the scalp in preparation for secondary reconstruction, the patient is often at risk of bleeding, seizure, stroke, and infection. In some cases, the replaced bone or implant must again be removed.

The new approach, called pericranial-onlay cranioplasty, involves pulling back only the top three layers of the five-layer scalp, thereby enabling the sandwiching the bone or implant in between the layers. The researchers say this innovation not only prevents brain injury, but also reduces infection risk by providing the delicate bone or implant access to blood supply in the scalp from both the top and the bottom layers.

In the study, the researchers reviewed 50 consecutive patients, encompassing 46 cranioplasties using the pericranial-onlay approach, along with 4 isolated temporal soft tissue reconstructions with liquid polymethyl methacrylate (PMMA). Of the 46 cranioplasties, only one autologous bone flap developed deep infection necessitating bone flap removal. None of the alloplastic custom implants has developed any infection requiring removal to date. The study describing the new technique was published on January 24, 2014, in the Journal of Neurosurgery.

“Everyone has been taught for 120 years to completely peel up the scalp,” said lead author craniofacial surgeon Chad Gordon, DO, an assistant professor of plastic and reconstructive surgery at JHU. “But by not disturbing the brain, we get much better outcomes. This is a safer, simpler way to do a very complex surgery.”

Ideally, surgeons restore the skull in the secondary cranial reconstruction procedure using with the same piece of bone removed during the original operation, which is stored in a freezer between operations. In some cases, surgeons must substitute the original bone with a custom-made implant made of PMMA, which has been used safely since the 1960s.

Related Links:

Johns Hopkins University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.